Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model.
Park DS, Oh S, Jin YJ, Na MH, Kim M, Kim JH, Hyun DY, Cho KH, Hong YJ, Kim JH, Ahn Y, Hermida-Prieto M, Vázquez-Rodríguez JM, Gutiérrez-Chico JL, Mariñas-Pardo L, Lim KS, Park JK, Byeon DH, Cho YN, Kee SJ, Sim DS, Jeong MH. Park DS, et al. Among authors: jeong mh. Tissue Eng Regen Med. 2024 Jan;21(1):53-64. doi: 10.1007/s13770-023-00608-y. Epub 2023 Nov 16. Tissue Eng Regen Med. 2024. PMID: 37973692
Preventive effects of the heparin-coated stent on restenosis in the porcine model.
Ahn YK, Jeong MH, Kim JW, Kim SH, Cho JH, Cho JG, Park CS, Juhng SW, Park JC, Kang JC. Ahn YK, et al. Among authors: jeong mh. Catheter Cardiovasc Interv. 1999 Nov;48(3):324-30. doi: 10.1002/(sici)1522-726x(199911)48:3<324::aid-ccd20>3.0.co;2-k. Catheter Cardiovasc Interv. 1999. PMID: 10525239
Initial and late results of Freedom coronary stent.
Ahn YK, Kang KT, Jeong MH, Kang JC, Park YK, Park OK. Ahn YK, et al. Among authors: jeong mh. Korean J Intern Med. 2000 Jan;15(1):8-12. doi: 10.3904/kjim.2000.15.1.8. Korean J Intern Med. 2000. PMID: 10714085 Free PMC article. Clinical Trial.
Long-term clinical benefits of a platelet glycoprotein IIb/IIIa receptor blocker, abciximab (ReoPro), in high-risk diabetic patients undergoing percutaneous coronary intervention.
Sim DS, Jeong MH, Kim W, Rhew JY, Yum JH, Kim JH, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC. Sim DS, et al. Among authors: jeong mh. Korean J Intern Med. 2003 Sep;18(3):129-37. doi: 10.3904/kjim.2003.18.3.129. Korean J Intern Med. 2003. PMID: 14619381 Free PMC article. Clinical Trial.
1,412 results